Abstract
Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in development and progression in various types of cancers, but its role in gastric cancer has not been fully elucidated. The purpose of this study was to investigate the levels of miR-146a expression and its function in human gastric cancer. Quantitative real-time polymerase chain reaction was used to detect the levels of miR-146a expression in gastric cancer tissue samples and cell lines. The cell growth rate of MKN-45 gastric cancer cells transfected with miR-146a mimics was examined by MTT assay. The effects of miR-146a on cell cycle and apoptosis were assessed by FACS analyses in MKN-45 cells. Thirty-six of 43 gastric cancer tissue samples (84%) showed decreased expression of miR-146a. We found low expression of miR-146a was correlated with increased tumor size (P = 0.006) and poor differentiation (P = 0.010) in gastric cancer. Overall survival time of patients with high miR-146a expression was significantly longer than that of patients with low expression of miR-146a (P = 0.011). The MTT assay showed that introduction of miR-146a inhibited cell proliferation in MKN-45 cells (P < 0.05). The proportion of apoptotic cells induced by transfection of miR-146a mimics were greater than that induced by transfection of the negative control mimics (11.9 vs. 5.9%). Our results suggested that miR-146a has potential as a novel suppressor gene in gastric cancer and its down-regulation may promote the progression of gastric cancer.
Similar content being viewed by others
Abbreviations
- miRNA:
-
MicroRNA
- miR-146a:
-
MicroRNA-146a
- qRT–PCR:
-
Quantitative real-time polymerase chain reaction
- FFPE:
-
Formaldehyde-fixed, paraffin-embedded
- MTT:
-
3-(4, 5-Dimethylthiazol-2-yl)-2, 4-diphenyl-tetrazolium bromide
References
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17–20.
Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 2006;12:192–8.
Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ. Dysregulation of cellular signaling in gastric cancer. Cancer Lett. 2010;295:144–53.
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell. 2005;120:15–20.
Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP. The widespread impact of mammalian micrornas on mrna repression and evolution. Science. 2005;310:1817–21.
Ambros V. The functions of animal micrornas. Nature. 2004;431:350–5.
Esquela-Kerscher A, Slack FJ. Oncomirs—micrornas with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
Croce CM. Causes and consequences of microrna dysregulation in cancer. Nat Rev Genet. 2009;10:704–14.
Xie L, Qian X, Liu B. Micrornas: novel biomarkers for gastrointestinal carcinomas. Mol Cell Biochem. 2010;341:291–9.
Shen R, Pan S, Qi S, Lin X, Cheng S. Epigenetic repression of microrna-129–2 leads to overexpression of sox4 in gastric cancer. Biochem Biophys Res Commun. 2010;394:1047–52.
Li L, Chen XP, Li YJ. Microrna-146a and human disease. Scand J Immunol. 2010;71:227–31.
Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH. Mir-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 2010;70:1486–95.
Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive micrornas in cervical cancer is required for cancer cell growth. PLoS One. 2008;3:e2557.
Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC. Expression of microrna-146 suppresses nf-kappab activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008;27:5643–7.
Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A. Nuclear factor-{kappa}b contributes to anaplastic thyroid carcinomas through up-regulation of mir-146a. J Clin Endocrinol Metab. 2010;95:1421–30.
Lin SL, Chiang A, Chang D, Ying SY. Loss of mir-146a function in hormone-refractory prostate cancer. RNA. 2008;14:417–24.
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common snp in pre-mir-146a decreases mature mir expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269–74.
Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates mir-146, which suppresses breast cancer metastasis. Cancer Res. 2009;69:1279–83.
Tchernitsa O, Kasajima A, Schafer R, Kuban RJ, Ungethum U, Gyorffy B, Neumann U, Simon E, Weichert W, Ebert MP, Rocken C. Systematic evaluation of the mirna-ome and its downstream effects on mrna expression identifies gastric cancer progression. J Pathol. 2010;222:310–9.
Boominathan L. The guardians of the genome (p53, ta-p73, and ta-p63) are regulators of tumor suppressor mirnas network. Cancer Metastasis Rev. 2010;29:613–39.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 81071815), Jiangsu Province Key Medical Cent Foundation and Scientific and Technological Innovation Plan Fund of Postgraduate from Jiangsu Province (No. 5X22013084).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hou, Z., Xie, L., Yu, L. et al. MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol 29, 886–892 (2012). https://doi.org/10.1007/s12032-011-9862-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-011-9862-7